Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Trends in Biochemical Sciences
- Vol. 35 (1), 53-61
- https://doi.org/10.1016/j.tibs.2009.08.004
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malariaBiochemical and Biophysical Research Communications, 2009
- Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaMalaria Journal, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaThe New England Journal of Medicine, 2008
- Development of bestatin-based activity-based probes for metallo-aminopeptidasesBioorganic & Medicinal Chemistry Letters, 2008
- Chemical Target Validation Studies of Aminopeptidase in Malaria Parasites Using α-Aminoalkylphosphonate and Phosphonopeptide InhibitorsAntimicrobial Agents and Chemotherapy, 2008
- BDA-410: A novel synthetic calpain inhibitor active against blood stage malariaMolecular and Biochemical Parasitology, 2007
- Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activityProceedings of the National Academy of Sciences of the United States of America, 2006
- Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systemsProceedings of the National Academy of Sciences of the United States of America, 2006
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002